TITLE

In vitro and in vivo evaluation of Dideco’s paediatric cardiopulmonary circuit for neonates weighing less than five kilograms

AUTHOR(S)
Thiara, A. S.; Eggereide, V.; Pedersen, T.; Lindberg, H.; Fiane, A. E.
PUB. DATE
July 2010
SOURCE
Perfusion;Jul2010, Vol. 25 Issue 4, p229
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The neonate cardiopulmonary bypass (CPB) circuit, including a KIDS D100 oxygenator (The Sorin Group, Mirandola, Italy) and a D130 arterial filter (The Sorin Group), was evaluated in vitro with respect to the removal of free micro gas bubbles. No gas bubbles > 40µm were measured after the arterial filter D130 upon manual introduction of 10 ml of air into the venous line or during the use of vacuum-assisted venous drainage (VAVD). The D130 arterial filter removed 88 % of gas bubbles < 40 µm during manual introduction of air into the venous line; however, only 50 % of gas bubbles < 40 µm were removed during the use of VAVD.The same CPB circuit was evaluated in vivo to compare with another CPB circuit, including a D901 oxygenator (The Sorin Group) and arterial filter D736 (The Sorin Group), in 155 neonates weighing ≤5 kg. The D100 circuit required significantly less priming volume than the D901 circuit. Postoperative haemoglobin was significantly higher, artificial ventilation time was significantly shorter and postoperative bleeding was significantly less in the D100 group. This neonate CPB circuit effectively removed the gas bubbles and required up to 37% less priming volume and, thus, decreased the need for blood transfusion.
ACCESSION #
62030372

 

Related Articles

  • An in vitro comparison of the ability of three commonly used pediatric cardiopulmonary bypass circuits to filter gaseous microemboli. Melchior, Richard W.; Rosenthal, Tami; Glatz, Andrew C. // Perfusion;Jul2010, Vol. 25 Issue 4, p255 

    Background: The purpose of this study was to compare the ability of three commonly used pediatric cardiopulmonary bypass (CPB) circuits to filter gaseous microemboli (GME) in an in vitro model. Methods: Devices were tested at different levels of two specific independent variables: volume of air...

  • Caring for Infants with Congenital Heart Disease and Their Families. Saenz, Rebecca B.; Beebe, Diane K.; Triplett, Laramie C. // American Family Physician;4/1/1999, Vol. 59 Issue 7, p1857 

    Points out that family physicians must be prepared to help the parents and other family members cope with the psychosocial aspects of congenital heart disease (CHD) in a child. Categories of congenital heart defects; Diagnosis of CHD; Factors that contribute to growth impairments in infants with...

  • EFFECT OF CARDIOPULMONARY BYPASS ON ANNEXIN A1 EXPRESSION IN PERIPHERAL BLOOD MONONUCLEAR CELLS OF CHILDREN WITH CONGENITAL HEART DISEASE. Zhou, Gengxu; Hong, Xiaoyang; Liu, Yuhang; Feng, Zhichun // Journal of Medical Biochemistry;Sep2012, Vol. 31 Issue 3, p193 

    This study aimed to investigate the effect of cardiopulmonary bypass (CPB) on Annexin A1 expression in the peripheral blood mononuclear cells (PBMCs) of children with congenital heart disease (CHD). A total of 30 children receiving CPB for interventricular septal defect were included. Peripheral...

  • Does heparin pretreatment affect the haemostatic system during and after cardiopulmonary bypass? Brinks, H.; Weerwind, P.; Bogdan, S.; Verbruggen, H.; Brouwer, M. // Perfusion;Jan2001, Vol. 16 Issue 1, p3 

    In this clinical pilot study, the influence of heparin pretreatment on the haemostatic system during and after cardiopulmonary bypass (CPB) was investigated. Thirteen patients scheduled for elective coronary artery bypass grafting (CABG) were divided into two groups: heparin pretreated (HP, n =...

  • Does heparin pretreatment affect the haemostatic system during and after cardiopulmonary bypass? Brinks, H.; Weerwind, P.; Bogdan, S.; Verbruggen, H.; Brouwer, M. // Perfusion;Jan2001, Vol. 16 Issue 1, p3 

    In this clinical pilot study, the influence of heparin pretreatment on the haemostatic system during and after cardiopulmonary bypass (CPB) was investigated. Thirteen patients scheduled for elective coronary artery bypass grafting (CABG) were divided into two groups: heparin pretreated (HP, n =...

  • ADHD & Congenital Heart Defects. GARILLI, BIANCA // Naturopathic Doctor News & Review;Mar2015, Vol. 11 Issue 3, p14 

    The article discusses the risk for attention-deficit hyperactivity disorder (ADHD) in children with congenital heart defects (CHD). It outlines several causes behind the ADHD prevalence in children including exposure to long-term hypoxia, use of cardiopulmonary bypass during open-heart surgery...

  • Recent advances in paediatric cardiac anaesthesia. Vakamudi, Mahesh; Ravulapalli, Harish; Karthikeyan, Ranjith // Indian Journal of Anaesthesia;Sep/Oct2012, Vol. 56 Issue 5, p485 

    Paediatric cardiac anaesthesia involves anaesthetizing very small children with complex congenital heart disease for major surgical procedures. The unique nature of this patient population requires considerable expertise and in-depth knowledge of the altered physiology. There have been several...

  • Levosimendan infusion in newborns after corrective surgery for congenital heart disease: randomized controlled trial. Ricci, Zaccaria; Garisto, Cristiana; Favia, Isabella; Vitale, Vincenzo; Di Chiara, Luca; Cogo, Paola // Intensive Care Medicine;Jul2012, Vol. 38 Issue 7, p1198 

    Purpose: To evaluate the safety and efficacy of levosimendan in neonates with congenital heart disease undergoing cardiac surgery with cardiopulmonary bypass (CPB). Methods: Neonates undergoing risk-adjusted classification for congenital heart surgery (RACHS) 3 and 4 procedures were randomized...

  • Perioperative Blood Lactate Levels, Pyruvate levels and Lactate/ Pyruvate Ratio in Children Undergoing Cardiopulmonary Bypass for Congenital Heart Disease. Shinde, Santosh; Golam, Kumud; Patil, Neela; Kumar, Pawan; Keshavan // Internet Journal of Anesthesiology;2006, Vol. 10 Issue 2, p11 

    Background: Cardiopulmonary bypass (CPB) affects almost every body system by hypoperfusion either subclinically or clinically and also produces a systemic inflammatory response due to contact of blood with mechanical surfaces. There has been no documentation, with regards to pyruvate, in...

Share

Read the Article

Courtesy of

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics